Researchers Point to Statistically Significant Autoimmune & Auto-Inflammatory Adverse Event Incidence Post COVID-19 Vax

Biomedical researchers from prominent academic research centers in both South Korea and the United States conducted a study identifying 3620 autoimmune-related adverse events among 223.2 million US residents using Vaccine Adverse Events Reporting System and the COVID-19 Data Tracker. Seong-Jan Kim an expert in nuclear medicine from Pusan National University Yangsan Hospital and Sung Ryul Shim, an epidemiological researcher at Konyang University and Yale University-based pharmaco-epidemiologist and mental health investigator Taeho Greg Rhee declare their recent investigation published in the journal Clinical Immunology is the first to quantify the cumulative incidence of autoimmune and auto-inflammatory adverse events after COVID-19 vaccination. This includes an accounting of autoimmune and auto-inflammatory adverse events across six major classes of medical conditions and stratified by age, sex, as well as COVID-19 vaccine manufacturer.

The study involves an accounting of the investigators’ initiative to estimate the cumulative incidence (CIR) of autoimmune and autoinflammatory adverse reactions per 100,000 people fully vaccinated against COVID-19 in the United States.